IBL Healthcare Ltd. (IBLHL) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 18.71%

Flat results in Mar 25

Risky -

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

PKR 6,579 Million (Small Cap)

P/E

24.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.17

Return on Equity

9.12%

Price to Book

2.75

Revenue and Profits:

Net Sales:

948 Million

(Quarterly Results - Mar 2025)

Net Profit:

35 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

50.48%

6 Months

28.86%

1 Year

69.55%

2 Years

112.2%

3 Years

80.04%

4 Years

-25.17%

5 Years

29.32%

IBL Healthcare Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

9.58%

EBIT Growth (5y)

5.81%

EBIT to Interest (avg)

10.43

Debt to EBITDA (avg)

1.92

Net Debt to Equity (avg)

0.15

Sales to Capital Employed (avg)

1.57

Tax Ratio

79.85%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

18.71%

ROE (avg)

12.45%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.17

EV to EBIT

12.31

EV to EBITDA

12.06

EV to Capital Employed

2.21

EV to Sales

1.15

PEG Ratio

0.02

Dividend Yield

ROCE (Latest)

17.92%

ROE (Latest)

8.97%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -15.18% vs 3.59% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -11.94% vs -32.89% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "948.00",
          "val2": "1,117.70",
          "chgp": "-15.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.70",
          "val2": "91.60",
          "chgp": "-22.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "15.50",
          "val2": "20.80",
          "chgp": "-25.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35.40",
          "val2": "40.20",
          "chgp": "-11.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "74.60%",
          "val2": "80.60%",
          "chgp": "-0.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is -10.54% vs 10.32% in Jun 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is -97.54% vs 2.01% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,603.40",
          "val2": "4,027.90",
          "chgp": "-10.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "82.00",
          "val2": "626.70",
          "chgp": "-86.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "67.40",
          "val2": "65.70",
          "chgp": "2.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.60",
          "val2": "309.00",
          "chgp": "-97.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.70%",
          "val2": "153.70%",
          "chgp": "-13.30%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

948.00

1,117.70

-15.18%

Operating Profit (PBDIT) excl Other Income

70.70

91.60

-22.82%

Interest

15.50

20.80

-25.48%

Exceptional Items

0.00

Consolidate Net Profit

35.40

40.20

-11.94%

Operating Profit Margin (Excl OI)

74.60%

80.60%

-0.60%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is -15.18% vs 3.59% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -11.94% vs -32.89% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jun'24

Jun'24

Jun'23

Change(%)

Net Sales

3,603.40

4,027.90

-10.54%

Operating Profit (PBDIT) excl Other Income

82.00

626.70

-86.92%

Interest

67.40

65.70

2.59%

Exceptional Items

-10.10

0.00

Consolidate Net Profit

7.60

309.00

-97.54%

Operating Profit Margin (Excl OI)

20.70%

153.70%

-13.30%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jun 2024 is -10.54% vs 10.32% in Jun 2023

Consolidated Net Profit

YoY Growth in year ended Jun 2024 is -97.54% vs 2.01% in Jun 2023

All Annual Results

Company CV

About IBL Healthcare Ltd.

IBL Healthcare Ltd.

Retailing

IBL HealthCare Limited is a Pakistan-based company engaged in marketing, selling and distribution of healthcare products. The Company is engaged in providing a range of healthcare and nutritional products. The Company's divisions include Mead Johnson Nutrition, Nestle Health Science, Brand Plus, Medical Disposable Division and Principle Health Care. The Mead Johnson Nutrition division offers approximately 70 products, such as Enfamama A+, Enfamil A+ Stage 1, Enfamil A+ Stage 2, Enfagrow A+ Stage 3 and Sustagen school 6+. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the challenges of different life stages. It offers products, such as Resource Diabetes and Resource Optimum. The Brand Plus division provides a range of baby cereals. The Medical Disposable division consist a range of medical disposables. The Principle Health Care division is a vitamin, mineral and food supplement producer.

Company Coordinates

Company Details

9th Floor, N.I.C. Building, Abbasi Shaheed Road KARACHI None : 75530

Tel: 92 21 37170200

http://www.iblhc.com/

Registrar Details